DOCK 5 activators represent a chemical class that can modulate the activity of the DOCK 5 protein by acting on its associated signaling pathways. These compounds mainly include various receptor agonists, ion channel modulators, and enzyme inhibitors. For example, Forskolin can elevate intracellular cAMP levels, which in turn activate a kinase cascade that may involve DOCK 5. Ionomycin increases calcium ion levels in the cell, a key factor in many signaling pathways that DOCK 5 is associated with. Similarly, Phorbol 12-myristate 13-acetate (PMA) targets the PKC pathway, offering another route for DOCK 5 modulation. Chemicals like VEGF and EGF act by initiating receptor-specific pathways that can intersect with DOCK 5 activity. In these instances, the activators act indirectly by initiating or modulating pathways that eventually influence the activity of DOCK 5.
Additionally, the chemical class incorporates phosphatase inhibitors like Sodium Orthovanadate and Calyculin A. These compounds inhibit the activity of phosphatases, which in turn can lead to the activation of DOCK 5. Lysophosphatidic Acid (LPA) and Bradykinin are another set of activators that target G-protein coupled receptors (GPCRs). These GPCRs can then go on to modulate a variety of intracellular pathways involving DOCK 5. This illustrates the broad scope and diverse biochemical mechanisms by which these chemicals can act to activate DOCK 5. Whether it's through kinase activation, receptor binding, or phosphatase inhibition, these chemicals offer different but effective routes to influence DOCK 5 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates cAMP levels which can activate a kinase cascade influencing DOCK 5. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular Ca2+ levels affecting pathways where DOCK 5 is active. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates the PKC pathway, potentially modulating DOCK 5. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Stimulates the MAPK pathway, which could activate DOCK 5. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Activates GPCRs that could modulate pathways involving DOCK 5. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Activates bradykinin receptors that can influence DOCK 5 activity. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Activates the angiotensin receptor, affecting pathways involving DOCK 5. | ||||||